vinpocetine has been researched along with Stroke in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 13 (54.17) | 29.6817 |
| 2010's | 10 (41.67) | 24.3611 |
| 2020's | 1 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| Panda, P; Panda, PK; Ramachandran, A; Sharawat, IK | 1 |
| Chen, J; Gong, Z; Hao, J; Liu, S; Ma, X; Shi, FD; Wei, C; Yan, C; Yao, Y; Zang, D; Zhang, F | 1 |
| Dan, Y; Li, C; Liu, Y; Lu, QL; Song, G; Xu, MS; Yin, Y | 1 |
| Chandra, A; Cheng, Z; Ding, Y; Du, H; Geng, X; Tong, Y; Zhu, H | 1 |
| Yang, L; Zhang, L | 1 |
| Hu, H; Huang, Y; Kong, Y; Li, C; Li, Y; Nao, J; Song, Y; Tan, L; Zhang, J; Zhang, W | 1 |
| Il'ves, AG; Kataeva, GV; Pozdniakov, AV; Prakhova, LN; Stoliarov, ID | 1 |
| Medhi, B; Modi, M; Patyar, S; Prakash, A | 1 |
| Gulyas, B; Halldin, C; Hillert, J; Kostulas, K; Shchukin, E; Toth, M; Vas, A | 1 |
| Airaksinen, A; Gulyás, B; Halldin, C; Hillert, J; Kostulas, K; Lindström, P; Schain, M; Tóth, M; Vas, A | 1 |
| Balogh, A; Fehér, G; Késmárky, G; Misnyovszky, M; Nagy, K; Németh, G; Németh, GY; Szapáry, L; Tóth, K; Tóth, T | 1 |
| Azimova, IuE; Tabeeva, GR | 1 |
| Dézsi, L; Kárpáti, E; Kis-Varga, I; Komlódi, Z; Nagy, J | 1 |
| Balkay, L; Bereczki, D; Bönöczk, P; Boros, I; Csiba, L; Emri, M; Fekete, I; Galuska, L; Gulyás, B; Kerényi, L; Lehel, S; Márián, T; Molnár, T; Nagy, Z; Szakáll, S; Szilágyi, G; Trón, L; Varga, J; Vas, A | 1 |
| Gaĭkova, ON; Ianishevskiĭ, SN; Onishchenko, LS | 1 |
| Bagoly, E; Fehér, G; Szapáry, L | 1 |
| Valikovics, A | 1 |
| Gaikova, ON; Onishchenko, LS; Yanishevskii, SN | 1 |
| Bereczki, D; Fekete, I | 2 |
| Balkay, L; Bereczki, D; Bönöczk, P; Boros, I; Csiba, L; Emri, M; Fekete, I; Galuska, L; Gulyás, B; Kerényi, L; Lehel, S; Márián, T; Molnár, T; Szakáll, S; Trón, L; Varga, J; Vas, A | 1 |
| Doronin, BM; Feigin, VL; Gribatcheva, EV; Popova, TF; Tchervov, DV | 1 |
| Bönöczk, P; Nagy, Z; Panczel, G | 1 |
9 review(s) available for vinpocetine and Stroke
| Article | Year |
|---|---|
Safety and Efficacy of Vinpocetine as a Neuroprotective Agent in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
Topics: Humans; Ischemic Stroke; Neuroprotective Agents; Randomized Controlled Trials as Topic; Stroke; Vinca Alkaloids | 2022 |
Vinpocetine in the treatment of poststroke cognitive dysfunction: A protocol for systematic review and meta-analysis.
Topics: Cognitive Dysfunction; Humans; Nootropic Agents; Quality of Life; Randomized Controlled Trials as Topic; Research Design; Stroke; Vinca Alkaloids | 2019 |
Anti-inflammatory effects of vinpocetine in atherosclerosis and ischemic stroke: a review of the literature.
Topics: Anti-Inflammatory Agents; Atherosclerosis; Brain Ischemia; Humans; Stroke; Vinca Alkaloids | 2014 |
Role of vinpocetine in cerebrovascular diseases.
Topics: Animals; Brain Ischemia; Cerebrovascular Disorders; Humans; Memory; Neuroprotective Agents; Nootropic Agents; Stroke; Vinca Alkaloids | 2011 |
[Vinpocetin in neurological diseases].
Topics: Animals; Anticonvulsants; Cerebrovascular Circulation; Cerebrovascular Disorders; Clinical Trials as Topic; Cognition; Cognition Disorders; Dementia, Vascular; Hemorheology; Humans; Microcirculation; Nervous System Diseases; Neuroprotective Agents; Stroke; Treatment Outcome; Vasodilator Agents; Vinca Alkaloids | 2012 |
Vinpocetine. Monograph.
Topics: Alzheimer Disease; Brain Ischemia; Calcium Channel Blockers; Hearing Disorders; Humans; Neuroprotective Agents; Nootropic Agents; Randomized Controlled Trials as Topic; Stroke; Vasodilator Agents; Vinca Alkaloids | 2002 |
[The role of vinpocetine in the treatment of cerebrovascular diseases based in human studies].
Topics: Acute Disease; Brain Ischemia; Cerebrovascular Circulation; Cerebrovascular Disorders; Chronic Disease; Glucose; Hemorheology; Humans; Neuroprotective Agents; Nootropic Agents; Quality of Life; Stroke; Treatment Outcome; Vasodilator Agents; Vinca Alkaloids | 2007 |
Vinpocetine for acute ischaemic stroke.
Topics: Brain Ischemia; Calcium Channel Blockers; Humans; Neuroprotective Agents; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke; Vasodilator Agents; Vinca Alkaloids | 2008 |
Vinpocetine for acute ischaemic stroke.
Topics: Brain Ischemia; Calcium Channel Blockers; Humans; Neuroprotective Agents; Platelet Aggregation Inhibitors; Stroke; Vasodilator Agents; Vinca Alkaloids | 2000 |
8 trial(s) available for vinpocetine and Stroke
| Article | Year |
|---|---|
Low dose concomitant treatment with chlorpromazine and promethazine is safe in acute ischemic stroke.
Topics: Adult; Aged; Aspirin; Atorvastatin; Chlorpromazine; Double-Blind Method; Drug Therapy, Combination; Edaravone; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Neuroprotective Agents; Platelet Aggregation Inhibitors; Promethazine; Stroke; Vinca Alkaloids | 2019 |
Efficacy and Safety of Vinpocetine as Part of Treatment for Acute Cerebral Infarction: A Randomized, Open-Label, Controlled, Multicenter CAVIN (Chinese Assessment for Vinpocetine in Neurology) Trial.
Topics: Aged; Anticoagulants; Aspirin; Cerebral Infarction; Cerebrovascular Circulation; China; Clopidogrel; Cognition; Female; Humans; Male; Middle Aged; Neuroprotective Agents; Neuropsychological Tests; Platelet Aggregation Inhibitors; Quality of Life; Stroke; Ticlopidine; Ultrasonography, Doppler, Transcranial; Vinca Alkaloids | 2016 |
[The multimodal strategy for the neuroprotection in stroke: results of the Russian multicenter clinical-epidemiological program SOKOL].
Topics: Administration, Oral; Adult; Aged; Antihypertensive Agents; Cytoprotection; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neuroprotective Agents; Russia; Stroke; Treatment Outcome; Vinca Alkaloids | 2012 |
Effects of vinpocetine on the redistribution of cerebral blood flow and glucose metabolism in chronic ischemic stroke patients: a PET study.
Topics: Brain Chemistry; Cerebrovascular Circulation; Chronic Disease; Double-Blind Method; Female; Functional Laterality; Glucose; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Stroke; Ultrasonography, Doppler, Transcranial; Vinca Alkaloids | 2005 |
[Investigation of the effect of vinpocetine on cerebral blood flow and cognitive functions].
Topics: Administration, Oral; Adult; Blood Flow Velocity; Brain Ischemia; Cerebrovascular Circulation; Cognition; Cognition Disorders; Dementia, Vascular; Female; Humans; Male; Middle Aged; Middle Cerebral Artery; Neuroprotective Agents; Nootropic Agents; Pilot Projects; Psychometrics; Severity of Illness Index; Stroke; Ultrasonography, Doppler, Transcranial; Vasodilator Agents; Vinca Alkaloids | 2007 |
[The effect of a single-dose intravenous vinpocetine on brain metabolism in patients with ischemic stroke].
Topics: Aged; Brain; Brain Ischemia; Glucose; Humans; Infusions, Intravenous; Middle Aged; Neuroprotective Agents; Stroke; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Vasodilator Agents; Vinca Alkaloids | 2001 |
Vinpocetine treatment in acute ischaemic stroke: a pilot single-blind randomized clinical trial.
Topics: Acute Disease; Aged; Brain Ischemia; Dextrans; Drug Combinations; Feasibility Studies; Female; Humans; Male; Middle Aged; Molecular Weight; Neuroprotective Agents; Pilot Projects; Severity of Illness Index; Single-Blind Method; Stroke; Treatment Outcome; Vinca Alkaloids | 2001 |
Vinpocetine increases cerebral blood flow and oxygenation in stroke patients: a near infrared spectroscopy and transcranial Doppler study.
Topics: Aged; Cerebrovascular Circulation; Female; Humans; Male; Oxygen Consumption; Spectroscopy, Near-Infrared; Stroke; Ultrasonography, Doppler, Transcranial; Vasodilator Agents; Vinca Alkaloids | 2002 |
7 other study(ies) available for vinpocetine and Stroke
| Article | Year |
|---|---|
Vinpocetine Inhibits NF-κB-Dependent Inflammation in Acute Ischemic Stroke Patients.
Topics: Adult; Aged; Brain Ischemia; C-Reactive Protein; Cytokines; Female; Follow-Up Studies; Gene Expression Regulation; Humans; Inflammation; Leukocytes, Mononuclear; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuroprotective Agents; NF-kappa B; RNA, Messenger; Statistics, Nonparametric; Stroke; Time Factors; Vinca Alkaloids | 2018 |
[Positron-emission tomography in the diagnosis of middle cerebral artery lesions].
Topics: Aged; Glucose; Humans; Infusions, Intravenous; Male; Middle Aged; Middle Cerebral Artery; Neuroprotective Agents; Positron-Emission Tomography; Prognosis; Stroke; Vinca Alkaloids | 2009 |
Visualising neuroinflammation in post-stroke patients: a comparative PET study with the TSPO molecular imaging biomarkers [11C]PK11195 and [11C]vinpocetine.
Topics: Aged; Binding Sites; Biomarkers; Carbon Radioisotopes; Encephalitis; Humans; Isoquinolines; Male; Middle Aged; Molecular Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, GABA; Stroke; Vinca Alkaloids; Young Adult | 2012 |
Evolution of microglial activation in ischaemic core and peri-infarct regions after stroke: a PET study with the TSPO molecular imaging biomarker [((11))C]vinpocetine.
Topics: Adult; Aged; Biomarkers; Brain Ischemia; Carbon Radioisotopes; Functional Neuroimaging; Humans; Infarction; Magnetic Resonance Imaging; Male; Microglia; Middle Aged; Molecular Imaging; Organ Size; Positron-Emission Tomography; Radioligand Assay; Receptors, GABA; Stroke; Time Factors; Up-Regulation; Vinca Alkaloids | 2012 |
[Neuroprotective effects of vinpocetine in vivo and in vitro. Apovincaminic acid derivatives as potential therapeutic tools in ischemic stroke].
Topics: Animals; Brain Ischemia; Disease Models, Animal; Humans; Ischemic Attack, Transient; Neuroprotective Agents; Rats; Stroke; Structure-Activity Relationship; Vinca Alkaloids | 2002 |
[Changes in the focus of experimental ischemic stroke under the influence of neuroprotective drugs].
Topics: Amino Acids; Animals; Brain; Brain Ischemia; Glycerylphosphorylcholine; Male; Neuroprotective Agents; Nootropic Agents; Piracetam; Rats; Stroke; Vinca Alkaloids | 2006 |
Changes at the focus of experimental ischemic stroke treated with neuroprotective agents.
Topics: Amino Acids; Animals; Brain; Brain Ischemia; Glycerylphosphorylcholine; Male; Neuroprotective Agents; Nootropic Agents; Piracetam; Rats; Recovery of Function; Stroke; Vinca Alkaloids | 2008 |